Gene · 55
Papers3,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 3,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic advances in hormone-dependent cancers: focus on prostate, breast and ovarian cancers. | Endocr Connect | 2019 | 30640710 | PubTator, text mining | PubMed |
| Sex hormone-binding globulin provides a novel entry pathway for estradiol and influences subsequent signaling in lymphocytes via membrane receptor. | Sci Rep | 2019 | 30626909 | PubTator, text mining | PubMed |
| Toll-like receptor 10 (TLR10) exhibits suppressive effects on inflammation of prostate epithelial cells. | Asian J Androl | 2019 | 30618413 | PubTator, text mining | PubMed |
| MicroRNA expression profile in chronic nonbacterial prostatitis revealed by next-generation small RNA sequencing. | Asian J Androl | 2019 | 30604696 | PubTator, text mining | PubMed |
| From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review). | Int J Oncol | 2019 | 30570109 | PubTator, text mining | PubMed |
| Neoadjuvant sipuleucel-T induces both Th1 activation and immune regulation in localized prostate cancer. | Oncoimmunology | 2019 | 30546940 | PubTator, text mining | PubMed |
| Protective effects of selenium and nano-selenium on bisphenol-induced reproductive toxicity in male rats. | Hum Exp Toxicol | 2019 | 30526071 | PubTator, text mining | PubMed |
| Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies. | Nat Rev Urol | 2019 | 30479377 | PubTator, text mining | PubMed |
| Perspective on Prostate Cancer Screening. | Clin Chem | 2019 | 30459166 | PubTator, text mining | PubMed |
| High-Throughput Stability Screening of Neoantigen/HLA Complexes Improves Immunogenicity Predictions. | Cancer Immunol Res | 2019 | 30425106 | PubTator, text mining | PubMed |
| iEKPD 2.0: an update with rich annotations for eukaryotic protein kinases, protein phosphatases and proteins containing phosphoprotein-binding domains. | Nucleic Acids Res | 2019 | 30380109 | PubTator, text mining | PubMed |
| Expression pattern of androgen receptor and AR-V7 in androgen-deprivation therapy-naïve salivary duct carcinomas. | Hum Pathol | 2019 | 30267779 | PubTator, text mining | PubMed |
| 50-Gy Stereotactic Body Radiation Therapy to the Dominant Intraprostatic Nodule: Results From a Phase 1a/b Trial. | Int J Radiat Oncol Biol Phys | 2019 | 30267761 | PubTator, text mining | PubMed |
| Prospective Immunophenotyping of CD8+ T Cells and Associated Clinical Outcomes of Patients With Oligometastatic Prostate Cancer Treated With Metastasis-Directed SBRT. | Int J Radiat Oncol Biol Phys | 2019 | 30205124 | PubTator, text mining | PubMed |
| The regulatory pathways leading to stem-like cells underlie prostate cancer progression. | Asian J Androl | 2019 | 30178777 | PubTator, text mining | PubMed |
| The Relationship between Dietary, Serum and Hair Levels of Minerals (Fe, Zn, Cu) and Glucose Metabolism Indices in Obese Type 2 Diabetic Patients. | Biol Trace Elem Res | 2019 | 30091069 | PubTator, text mining | PubMed |
| TiO2 surfaces self-doped with Ag nanoparticles exhibit efficient CO2 photoreduction under visible light. | RSC Adv | 2018 | 35542239 | PubTator, text mining | PubMed |
| Redox regulation & sperm function: A proteomic insight. | Indian J Med Res | 2018 | 30964084 | PubTator, text mining | PubMed |
| How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation. | Nat Biomed Eng | 2018 | 30931172 | PubTator, text mining | PubMed |
| The Coming Age of Insect Cells for Manufacturing and Development of Protein Therapeutics. | Ind Eng Chem Res | 2018 | 30886455 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55/papers?page=47